(Q39607978)

13 September 2017

Immunology, autoimmunity, and autoantibodies in Parkinson's disease (English)

1 reference

13 September 2017

1 reference

12

Yehuda Shoenfeld

1 reference

13 September 2017

10

Miri Blank

1 reference

13 September 2017

2

Nancy Agmon-Levin

1 reference

13 September 2017

11

Joab Chapman

1 reference

Oscar-Danilo Ortega-Hernandez

13 September 2017

5

object named as

Oscar-Danilo Ortega-Hernandez

1 reference

13 September 2017

Martine Szyper-Kravitz

8

object named as

Martine Szyper-Kravitz

1 reference

13 September 2017

9

Maya Damianovich

1 reference

13 September 2017

1

Michal Benkler

1 reference

13 September 2017

Sharon Hassin-Baer

3

1 reference

13 September 2017

Oren S Cohen

4

1 reference

13 September 2017

Amalia Levy

6

1 reference

13 September 2017

Samuel-Datum Moscavitch

7

1 reference

13 September 2017

1 April 2012

1 reference

Clinical Reviews in Allergy & Immunology

13 September 2017

1 reference

13 September 2017

42

1 reference

13 September 2017

2

1 reference

13 September 2017

164-171

1 reference

https://scigraph.springernature.com/pub.10.1007/s12016-010-8242-y

13 September 2017

0 references

cites work

Alzheimer's disease and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Functional anatomy of movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Olfactory pathogenesis of idiopathic Parkinson disease revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Parkinson's disease, autoimmunity, and olfaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Parkinson's disease and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Autoantibodies to alpha-synuclein in inherited Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Effects of cerebrospinal fluid from patients with Parkinson disease on dopaminergic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

A possible role for humoral immunity in the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Role of Fcgamma receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Pharmacological analysis of human D1 AND D2 dopamine receptor missense variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Immunoblot and immunohistochemical comparison of murine monoclonal antibodies specific for the rat D1a and D1b dopamine receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Antibodies Against Synthetic Peptides Predicted from the Nucleotide Sequence of D2Receptor Recognize Native Dopamine Receptor Protein in Rat Striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Preparation and characterization of an antibody specific to the rat dopamine D2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Evidence for a dopamine receptor antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Updating on the pathogenesis of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Are autoantibodies triggering endothelial cell apoptosis really pathogenic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Antineuronal antibodies in a group of children with obsessive-compulsive disorder and Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Antineural antibody in patients with Tourette's syndrome and their family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Antineuronal antibodies in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Systemic lupus erythematosus: clinical presentations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS -SLE (depression).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

To smell autoimmunity: anti-P-ribosomal autoantibodies, depression, and the olfactory system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Clinical and biological aspects of anti-P-ribosomal protein autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Depression is an early disease manifestation in lupus-prone MRL/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Autoimmune pathology accounts for common manifestations in a wide range of neuro-psychiatric disorders: the olfactory and immune system interrelationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Neurolupus is associated with anti-ribosomal P protein antibodies: An inception cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8242-Y

Neuropsychiatric manifestations of systemic lupus erythematosus - A primary disease manifestation

21 January 2018

1 reference

12 December 2020

Cerebellar ataxia as a possible organ-specific autoimmune disease

1 reference

12 December 2020

The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases--2008.

1 reference

12 December 2020

Anti-GM1 ganglioside antibodies in Parkinson's disease

1 reference

12 December 2020

Antineuronal antibodies in rheumatic chorea.

1 reference

12 December 2020

Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides.

1 reference

12 December 2020

Automimmune response to dopamine-receptor as a possible mechanism in the pathogenesis of Parkinson's disease and schizophrenia

1 reference

12 December 2020

gamma delta+ T cells are increased in patients with Parkinson's disease

1 reference

12 December 2020

Subthalamic stimulation for Parkinson's disease

1 reference

12 December 2020

Anti-ribosomal-P antibodies in lupus patients and healthy controls: evaluation of three ELISA assays.

1 reference

12 December 2020

Double-blind study with phosphatidylserine (PS) in parkinsonian patients with senile dementia of Alzheimer's type (SDAT).

1 reference

12 December 2020

10.1007/S12016-010-8242-Y

Identifiers

DOI

1 reference

13 September 2017

1 reference